J & j news
You're looking for news related to Johnson & Johnson (J&J), a multinational medical devices, pharmaceutical, and consumer packaged goods manufacturer. Here are some recent news articles and updates:
Recent News:
- J&J to pay $2.1 billion to settle opioid lawsuits: Johnson & Johnson has agreed to pay $2.1 billion to settle thousands of lawsuits alleging that the company's marketing and sales practices contributed to the opioid epidemic. (Source: Reuters, March 2023)
- J&J's COVID-19 vaccine gets EU approval: The European Union has approved Johnson & Johnson's COVID-19 vaccine, Ad26.COV2.S, for use in adults. (Source: Bloomberg, March 2023)
- J&J to acquire Momenta Pharmaceuticals: Johnson & Johnson has agreed to acquire Momenta Pharmaceuticals, a biotechnology company focused on developing treatments for autoimmune diseases. (Source: CNBC, February 2023)
- J&J recalls baby powder due to asbestos contamination: Johnson & Johnson has recalled several lots of its baby powder due to the presence of asbestos, a known carcinogen. (Source: CNN, January 2023)
Recent Updates:
- J&J's quarterly earnings beat expectations: Johnson & Johnson reported stronger-than-expected quarterly earnings, driven by growth in its pharmaceutical and medical devices segments. (Source: MarketWatch, January 2023)
- J&J launches new cancer treatment: Johnson & Johnson has launched a new cancer treatment, Zepzelca, which is designed to treat small cell lung cancer. (Source: Medical News Today, December 2022)
- J&J partners with biotech company to develop new cancer therapies: Johnson & Johnson has partnered with biotech company, Bicycle Therapeutics, to develop new cancer therapies using Bicycle's proprietary technology. (Source: FierceBiotech, November 2022)
These are just a few examples of recent news and updates related to Johnson & Johnson. If you're looking for more information, I can try to help you find it!